Therefore, we aimed to assess the relationship between genetic variation in STXBP5 and STX2, VWF:Ag levels, and the bleeding phenotype in patients previously diagnosed with type 1 VWD. This evidence concerns the gene STXBP5 and von Willebrand disease 1.